Baricitinib was approved by FDA recently for
barcitinib is a janus kinase inhibitoe JAK . Ihibits the activity of JAK 1 and JAK 2 enzymes interfering with JAK STAT pathway.
Osteo ahritis
R ahritis
Cl difficale
Gout
All India exam